Agreement: Page 5

Beckman, Scopio to partner on blood smear platforms

By LabPulse.com staff writers

Scopio's technology employs full-field imaging and artificial intelligence (AI) decision support with the aim of eliminating manual microscopy. The platform allows full-field images to be shared in real-time over a secure hospital network and captures large scan areas at 100X magnification.

July 19, 2022

Genetic Technologies completes AffinityDNA asset purchase

By LabPulse.com staff writers

Under the terms of the agreement, Genetic Technologies has acquired all of AffinityDNA's assets including websites, brand identities, laboratory testing, and distribution agreements.

July 14, 2022

Nucleai, Sirona Dx partner on tumor biomarker discovery

By LabPulse.com staff writers

The partnership combines Nucleai's artificial intelligence (AI) spatial analytics platform with Sirona Dx's multiplex assay development expertise to identify novel spatial signatures in high-plex assays that predict responses to therapy and inform treatment decisions.

July 13, 2022

DNAnexus, Twist Bioscience partner on NGS data analysis

By LabPulse.com staff writers

As part of the collaboration, Twist customers can simplify data analysis after sequencing using the integrated DNAnexus platform with Twist's NGS Methylation Detection System and Unique Molecular Identifier (UMI) Adapter System, the firms said.

July 12, 2022

Quotient, Infynity partner on infectious disease testing

By LabPulse.com staff writers

Quotient said that under the agreement Infynity Biomarkers will assist it with the research and design of infectious disease assays to expand its MosaiQ Serology Disease Screening (SDS) menu, as well as reduce the time and cost of development and commercialization.

July 11, 2022

OpGen Q2 preliminary revenues rise 25%

By LabPulse.com staff writers

As of June 30, OpGen had approximately $16.6 million in cash.

July 7, 2022

Medial EarlySign, Roche partner on lung cancer detection

By LabPulse.com staff writers

The goal is to deliver validated clinical machine learning models for lung cancer detection with EarlySign's LungFlag technology. The technology uses a variety of signals, including basic demographic, medical, drug, and routine clinical lab data.

July 7, 2022

SD Biosensor, SJL Partners to acquire Meridian Bioscience

By Leo O'Connor

Under the terms of the agreement, shareholders of Cincinnati, OH-based Meridian Bioscience will receive $34 per share in cash, which represents a premium of 16% compared to the firm's one-month average price per share starting Thursday.

July 6, 2022

Etiometry, Radiometer partner to enhance NICU workflows

By LabPulse.com staff writers

The partnership pairs Etiometry's platform for creating holistic views across the patient care continuum with Radiometer's transcutaneous monitoring (TCM) system for monitoring ventilation of neonatal patients.

June 29, 2022

Boehringer Ingelheim, BiomX partner on IBD biomarkers

By LabPulse.com staff writers

BiomX said that under the collaboration, it will utilize its XMarker microbiome-based biomarker discovery platform with the goal of identifying biomarkers for a pathogenic bacterium thought to be associated with IBD.

June 27, 2022

CDC, CAP ink MOU addressing surge testing

By LabPulse.com staff writers

CAP said on Monday that under the memorandum, it will collaborate with the CDC and other partners and government agencies to support surge testing capacity when public health emergencies and emerging public health threats arise.

June 26, 2022

AstraZeneca, G42 Healthcare aim to collaborate

By LabPulse.com staff writers

According to the Department of Health in Abu Dhabi, G42 Healthcare and AstraZeneca had already signed a declaration of collaboration in December 2021.

June 20, 2022

Previous Page

Page 5 of 16

Next Page